Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.88 USD | -7.75% | -11.47% | -57.25% |
05-08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
05-08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.25% | 515M | |
+42.60% | 748B | |
+32.99% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.97% | 245B | |
+8.78% | 211B | |
-4.38% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 04, 2021